Tilray Brands (TLRY) Gross Margin (2017 - 2026)

Tilray Brands (TLRY) posted Gross Margin of 26.58% for Q1 2026, up 0.56% on a QoQ basis from 26.43% in Q4 2025, and down 141.0% year-over-year from 64.83% in Q1 2025.

Tilray Brands (TLRY) Gross Margin (2017 - 2026) Analysis & Trends

Tilray Brands' Gross Margin history runs 10 years deep, the most recent figure standing at 26.58% for Q1 2026.

  • Quarterly Gross Margin fell 141.0% year-over-year to 26.58% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 27.68% (down 320.0% YoY) and the FY2025 annual result came in at 29.29%, up 98.0% from the prior year.
  • Gross Margin was 26.58% for Q1 2026 at Tilray Brands, up from 26.43% in the prior quarter.
  • Across five years, Gross Margin topped out at 36.46% in Q2 2023 and bottomed at 8.04% in Q1 2023.
  • A 5-year average of 24.75% and a median of 27.43% in 2025 frame the typical range for Gross Margin.
  • Peak annual rise in Gross Margin reached 4086 bps in 2023, while the deepest fall reached 3426 bps in 2023.
  • Tilray Brands' Gross Margin stood at 29.75% in 2022, then declined by 18 bps to 24.47% in 2023, then grew by 19 bps to 29.02% in 2024, then declined by 9 bps to 26.43% in 2025, then rose by 1 bps to 26.58% in 2026.
  • Business Quant data shows TLRY's Gross Margin at 26.58% in Q1 2026, 26.43% in Q4 2025, and 27.43% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn 26.58%

Historic Data

Download Data
DateValue
Feb 28, 2026 26.58%
Nov 30, 2025 26.43%
Aug 31, 2025 27.43%
May 31, 2025 30.12%
Feb 28, 2025 28.00%
Nov 30, 2024 29.02%
Aug 31, 2024 29.85%
May 31, 2024 35.82%
Feb 29, 2024 26.23%
Nov 30, 2023 24.47%
Aug 31, 2023 24.98%
May 31, 2023 36.46%
Feb 28, 2023 -8.04%
Nov 30, 2022 29.75%
Aug 31, 2022 31.73%
May 31, 2022 -4.39%
Feb 28, 2022 26.23%
Nov 30, 2021 21.12%
Aug 31, 2021 30.33%
May 31, 2021 15.82%